Contrive Datum Insights recent study on the “Global Hepatitis B Diagnostic Tests Market” (By Product Type (Enzyme Immunoassay Kits (Hepatitis B Surface Antigen Test, Anti-Hepatitis B Surface Antibody Test, Anti-hepatitis B core antibody test), Point-of-care Testing Kits (Strips, Cassettes/Cards)); By End User (Hospitals, Diagnostic Centers, Clinics, Home Care); 2019 – 2026 offers industry insights, growth perspective and dynamics about the competitiveness in the market.
Inflammation and damage of liver due to viral hepatitis infection is termed as hepatitis. Inflammation obtained through the affectability of virus could lead to the damage of organs. Thus, the epidemic distinct disease has been categorized as hepatitis A, hepatitis B and many more. The epidemic substantiality of the disease was recognized since 1940s and was diagnosed through using specific serologic tests. However, in the current scenario, widespread of the hepatitis B virus has affected around 2 billion individuals across the globe and 248 million among them are witnessed to have chronic infections throughout their life. Increase in hepatitis B diseases, demands for efficient diagnostic tests in order to anticipate to the origin and assessment of disease before turning into chronic. Global hepatitis B diagnostic tests market is estimated to attain growth at a CAGR of XX% over the forecast period (2019 – 2026), owing to the rise in hepatitis B diseases.
Increase in hepatitis B diseases demand for diagnostic tests in order to detect early symptoms.
Hepatitis B viruses comprised of antigenic compounds such as hepatitis B core antigen (HBcAg), HBsAg and hepatitis B e antigen (HBeAg). These viruses have small double shelled DNA genome and hosts primarily on humans. Infections and affectability of virus can cause chronic and acute cirrhosis. Furthermore, the epidemic result of disease can also cause hepatocellular carcinomas (HCC). In addition, based on the U.S. Department of Health & Human Services, it is observed that more than 850,000 individuals are living with hepatitis and 21000 infections among them occur each year. Moreover, based on the estimation of .S. Department of Health & Human Services it is also noticed that 50 percent of U.S. individuals carrying hepatitis B are Asian. As a result, owing to the increase in widespread disease of hepatitis B viruses from infants to elderly population demands for preventive diagnostic kits. Hence, a development in hepatitis B diagnostic tests market is anticipated.
Increase in awareness participation by government and non-profit organization for diagnosing hepatitis B is leveraging the market
Hepatitis B could affect from mild illness to a lifelong chronic infection. The effect of virus among could lead to chronic infection among 90 percent of unimmunized infants and around 6 to 7 percent of adults and children are likely to get infect with chronic hepatitis B. Thus, with the increasing prevalence of hepatitis B has enabled in the rise in awareness level and early detection across all age groups. Hence, government and non-profit organization are increasingly undertaking initiatives to raise the awareness level and provide efficient diagnostic tests. For instance, Hepatitis B Foundation, a non-profit organization partnered with Association of Asian Pacific Community Health Organization (AAPCHO) to increase and enhance, the awareness and diagnosis of hepatitis B among local communities, countries and regional level. Based on the participation of organization more than 30 members in 26 cities are currently actively involved towards raising the awareness programs.
Global Hepatitis B Diagnostic Tests Market, Revenue (USD Million), 2019 – 2026
The competitive landscape of the global hepatitis B diagnostic tests market consists of several global and regional players. Some of the players in the market include Abbott, Biogate Laboratories Ltd., bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., General Biologicals Corporation, J.Mitra & Company PVT LTD (JMPL), Meridian Life Science, Inc., Siemens Healthcare GmbH, Vista Diagnostics International amongst others.
Hepatitis B Diagnostic Tests Product Type, Overview, 2019 – 2026 (USD Million)
- Personal Care and Cosmetics
- Food and Beverage
Hepatitis B Diagnostic Tests End User, Overview, 2019 – 2026 (USD Million)
- Specialty Store
- Drug Store